期刊
CELL
卷 162, 期 5, 页码 961-973出版社
CELL PRESS
DOI: 10.1016/j.cell.2015.07.056
关键词
-
资金
- Cancer Research Society [CRS19092, CRS19091]
- Canadian Cancer Society [CCSRI 703279, CCSRI 703716]
- NSERC [489073]
- Ontario Institute for Cancer Research (OICR)
- province of Ontario
- Princess Margaret Cancer Foundation
- University of Toronto McLaughlin Centre [MC-2015-02]
- NCI [5R01CA082422]
- Stand Up to Cancer
DNA-demethylating agents have shown clinical antitumor efficacy via an unknown mechanism of action. Using a combination of experimental and bioinformatics analyses in colorectal cancer cells, we demonstrate that low-dose 5-AZA-CdR targets colorectal cancer-initiating cells (CICs) by inducing viral mimicry. This is associated with induction of dsRNAs derived at least in part from endogenous retroviral elements, activation of the MDA5/MAVS RNA recognition pathway, and downstream activation of IRF7. Indeed, disruption of virus recognition pathways, by individually knocking down MDA5, MAVS, or IRF7, inhibits the ability of 5-AZA-CdR to target colorectal CICs and significantly decreases 5-AZA-CdR long-term growth effects. Moreover, transfection of dsRNA into CICs can mimic the effects of 5-AZA-CdR. Together, our results represent a major shift in understanding the anti-tumor mechanisms of DNA-demethylating agents and highlight the MDA5/MAVS/IRF7 pathway as a potentially druggable target against CICs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据